Long-term impact of bariatric surgery in diabetic nephropathy
- PMID: 30251143
- DOI: 10.1007/s00464-018-6458-8
Long-term impact of bariatric surgery in diabetic nephropathy
Abstract
Background: Bariatric surgery has been shown to improve and resolve diabetes. However, limited literature about its impact on end-organ complications of diabetes is available. The aim of this study was to examine the long-term effect of bariatric surgery on albuminuria.
Methods: We studied 101 patients with pre-operative diabetes and albuminuria [defined as urine albumin:creatinine ratio (uACR) > 30 mg/g] who underwent bariatric surgery at an academic center from 2005 to 2014.
Results: Fifty-seven patients (56%) were female with a mean age of 53 (± 11) years. The mean pre-operative BMI and glycated hemoglobin (HbA1c) were 43.1 (± 7.6) kg/m2 and 8.4 (± 1.8)%, respectively. The median pre-operative uACR was 80.0 (45.0-231.0) mg/g. Bariatric procedures included Roux-en-Y gastric bypass (n = 75, 74%) and sleeve gastrectomy (n = 26, 26%). The mean follow-up period was 61 (± 29) months. At last follow-up, the mean BMI was 33.8 (± 8.3) kg/m2. The overall glycemic control improved after bariatric surgery. At last follow-up, 73% had good glycemic control (HbA1c < 7%) and 27% met diabetes remission criteria. The mean HbA1c at last follow-up was 6.7 (± 1.0)% and the median uACR was 30 (IQR 7-94) mg/g. Albuminuria improved in 77% and resolved in 51% of patients at long-term.
Conclusions: Bariatric surgery has a significantly positive impact on albuminuria in patients with obesity and type 2 diabetes. Our data showed almost an 80% improvement in albuminuria at the short- and long-term period after bariatric surgery.
Keywords: Albuminuria; Bariatric surgery; Diabetes; Gastric bypass; Nephropathy; Sleeve gastrectomy.
Similar articles
-
Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up.Surg Obes Relat Dis. 2013 Jan-Feb;9(1):7-14. doi: 10.1016/j.soard.2012.08.016. Epub 2012 Oct 12. Surg Obes Relat Dis. 2013. PMID: 23211651
-
Development of De Novo Diabetes in Long-Term Follow-up After Bariatric Surgery.Obes Surg. 2018 Aug;28(8):2247-2251. doi: 10.1007/s11695-018-3194-z. Obes Surg. 2018. PMID: 29524184
-
Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus.Obes Surg. 2017 Mar;27(3):795-801. doi: 10.1007/s11695-016-2372-0. Obes Surg. 2017. PMID: 27644433
-
The Impact of Metabolic and Bariatric Surgery on Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis.Obes Surg. 2025 Jan;35(1):329-340. doi: 10.1007/s11695-024-07612-8. Epub 2024 Dec 10. Obes Surg. 2025. PMID: 39656373
-
Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.Ann Surg. 2015 Mar;261(3):459-67. doi: 10.1097/SLA.0000000000000863. Ann Surg. 2015. PMID: 25361217 Review.
Cited by
-
Significant Promising Effects of Bariatric Surgery on the Biochemical Control of Glycemia and Lipidemia in Diabetic Patients in Western Saudi Arabia: A Tertiary Center Experience and a Retrospective Study.Cureus. 2024 Jan 31;16(1):e53295. doi: 10.7759/cureus.53295. eCollection 2024 Jan. Cureus. 2024. PMID: 38435872 Free PMC article.
-
Sleeve gastrectomy links the attenuation of diabetic kidney disease to the inhibition of renal tubular ferroptosis through down-regulating TGF-β1/Smad3 signaling pathway.J Endocrinol Invest. 2024 Jul;47(7):1763-1776. doi: 10.1007/s40618-023-02267-1. Epub 2024 Mar 21. J Endocrinol Invest. 2024. PMID: 38512446 Free PMC article.
-
Comparative Analysis of Renal Function Outcomes Following Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Systematic Review and Meta-analysis.Obes Surg. 2025 Feb;35(2):587-601. doi: 10.1007/s11695-025-07669-z. Epub 2025 Jan 8. Obes Surg. 2025. PMID: 39775393
-
Effect of Conventional Medical Therapy or Laparoscopic Sleeve Gastrectomy on Urinary Albumin in Japanese Subjects with Severe Obesity: An Observational Study.Obes Facts. 2021;14(6):613-621. doi: 10.1159/000519156. Epub 2021 Oct 14. Obes Facts. 2021. PMID: 34649255 Free PMC article.
-
Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches.Nutrients. 2022 Nov 13;14(22):4801. doi: 10.3390/nu14224801. Nutrients. 2022. PMID: 36432488 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous